» Articles » PMID: 12531920

Understanding Missense Mutations in the BRCA1 Gene: an Evolutionary Approach

Overview
Specialty Science
Date 2003 Jan 18
PMID 12531920
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

The role of missense changes in BRCA1 in breast cancer susceptibility has been difficult to establish. We used comparative evolutionary methods to identify potential functionally important amino acid sites in exon 11 and missense changes likely to disrupt gene function, aligning sequences from 57 eutherian mammals and categorizing amino acid sites by degree of conservation. We used Bayesian phylogenetic analyses to determine relationships among orthologs and identify codons evolving under positive selection. Most conserved residues occur in a region with the highest concentration of protein-interacting domains. Rapidly evolving residues are concentrated in the RAD51-interacting domain, suggesting that selection is acting most strongly on the role of BRCA1 in DNA repair. Investigation of the functional role of missense changes in breast-cancer susceptibility should focus on 38 missense changes in conserved and 3 in rapidly evolving regions of exon 11.

Citing Articles

A global perspective on the ethnic-specific variation and its implication in clinical application.

Wang S J Natl Cancer Cent. 2024; 3(1):14-20.

PMID: 39036311 PMC: 11256725. DOI: 10.1016/j.jncc.2022.12.001.


Pathogenic variants in human DNA damage repair genes mostly arose after the latest human out-of-Africa migration.

He J, Kou S, Li J, Ding X, Wang S Front Genet. 2024; 15:1408952.

PMID: 38948361 PMC: 11211533. DOI: 10.3389/fgene.2024.1408952.


An efficient qPCR assay for the quantification of human cells in preclinical animal models by targeting human specific DNA in the intron of BRCA1.

Liu K, Hu L, Wang S, Chen X, Liu Y, Zhao S Mol Biol Rep. 2023; 50(11):9229-9237.

PMID: 37805662 DOI: 10.1007/s11033-023-08853-z.


Human pathogenic variants were originated during recent human history.

Li J, Zhao B, Huang T, Qin Z, Wang S Life Sci Alliance. 2022; 5(5).

PMID: 35165121 PMC: 8860097. DOI: 10.26508/lsa.202101263.


Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance.

Ozgencil M, Barwell J, Tischkowitz M, Izatt L, Kesterton I, Simpson M PLoS One. 2021; 16(12):e0260852.

PMID: 34855882 PMC: 8638976. DOI: 10.1371/journal.pone.0260852.


References
1.
Orelli B, Logsdon Jr J, Bishop D . Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene. 2001; 20(32):4433-8. DOI: 10.1038/sj.onc.1204485. View

2.
Shen D, Vadgama J . BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC). Oncol Res. 1999; 11(2):63-9. View

3.
Barker D, Almeida E, Casey G, Fain P, Liao S, Masunaka I . BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype. Genet Epidemiol. 1996; 13(6):595-604. DOI: 10.1002/(SICI)1098-2272(1996)13:6<595::AID-GEPI5>3.0.CO;2-#. View

4.
Abel K, Xu J, Yin G, Lyons R, Meisler M, Weber B . Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. Hum Mol Genet. 1995; 4(12):2265-73. DOI: 10.1093/hmg/4.12.2265. View

5.
Newman B, Mu H, Butler L, Millikan R, Moorman P, King M . Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA. 1998; 279(12):915-21. DOI: 10.1001/jama.279.12.915. View